PUBLICATIONS DES MEMBRES

Commercially available genomic-based signatures in early breast cancer: Is it ready for tomorrow morning?
2015 - Gonçalves A,Penault-Llorca F Bull Cancer n°102 - pp 100-1
Comparison Bricker's and Wallace's anastomoses in ileal conduit: Retrospective, multicenter study
2015 - Delaume A,Védrine N,Guandalino M,Mulliez A,Bruyère F,Boiteux JP,Guy L Prog urol n°14 - pp 1
Complex archaea that bridge the gap between prokaryotes and eukaryotes
2015 - Spang A,Saw JH,Jorgensen SL,Zaremba-Niedzwiedzka K,Martijn J,Lind AE,Vaneijk R,Schleper C,Guy L,Ettema TJ Nature n°521(7551) - pp 173-9
Consanguinity Protecting Effect Against Breast Cancer among Tunisian Women: Analysis of BRCA1 Haplotypes
2015 - Medimegh I,Troudi W,Omrane I,Ayari H,Uhrhummer N,Majoul H,Benayed F,Mezlini A,Bignon YJ,Sibille C,Elgaaied AB Asian Pac J Cancer Prev n°16(9) - pp 4051-5
DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition
2015 - Ollier M,Radosevic-Robin N,Kwiatkowski F,Ponelle F,Viala S,Privat M,Uhrhammer N,Bernard-Gallon D,Penault-Llorca F,Bignon YJ,Bidet Y Am J Cancer Res n°5(7) - pp 2113-6
Étude de la marque H3K27me3 à l'échelle du génome : mise en place d'un profil épigénétique en fonction de l'agressivité du cancer de la prostate
2015 - Ngollo M,Lebert A,Daures M,Penault-Llorca F,Bernard-Gallon D,Guy L Prog Urol n°25 - pp 757
Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line
2015 - Pouget M,Abrial C,Planchat E,Vanpraagh I,Arbre M,Kwiatkowski F,Dubray-Longeras P,Devaud H,Dohou J,Herviou P,Mahammedi H,Durando X,Chollet P,Mouret-Reynier MA Oncology n°89(6) - pp 319-31
Exercise Cardiac Output Limitation in Pectus Excavatum
2015 - Tardy-Medous MM,Filaire M,Patoir A,Gautier-Pignonblanc P,Galvaing G,Kwiatkowski F,Costes F,Ruddy R J Am Coll Cardiol n°66(8) - pp 976-7
French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas
2015 - Lantuejoul S,Rouquette I,Blons H,Lestang N,Llie M,Begueret H,Gregoire V,Hofman P,Gros A,Garcia S,Monhoven N,Devouassoux-Shisheboran M,Mansuet-Lupo A,Thivolet F,Antoine M,Vignaud JM,Penault-Llorca F,Galateau-Salle F,McLeer-Florin A Eur Respir J n°30 - pp 1
Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer?
2015 - karsli-Ceppioglu S,Ngollo M,Adjakly M,Dagdemir A,Judes G,Lebert A,Boiteux JP,Penault-Llorca F,Bignon YJ,Guy L,Bernard-Gallon D OMICS n°19 - pp 209-219
Guidance of Drosophila Mushroom Body Axons Depends upon DRL-Wnt Receptor Cleavage in the Brain Dorsomedial Lineage Precursors
2015 - Reynaud E,Lahaye LL,Boulanger A,Petrova IM,Marquilly C,Flandre A,Martianez T,Privat M,Noordermeer JN,Fradkin LG,Dura JM Cell Rep n°11(8) - pp 1293-1304
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative
2015 - Gourgou-Bourgade S,Cameron D,Poortmans P,Asselain B,Azria D,Cardoso F,Ahern R,Bliss J,Bogaerts J,Bonnefoi H,Brain E,Cardoso MJ,Chibaudel B,Coleman R,Cufer T,Dallago L,Dalenc F,Deazambuja E,Debled M,Delaloge S,Filleron T,Gligorov J,Gutowski M,Jacot W,Kirkove C,MacGrogan G,Michiels S,Negreiros I,Offersen BV,Penault-Llorca F,Pruneri G,Roche H,Russell NS Ann Oncol n°76(1) - pp 25-41
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
2015 - Gourgou-Bourgade S,Cameron D,Poortmans P,Asselain B,Azria D,Cardoso F,Ahern R,Bliss J,Bogaerts J,Bonnefoi H,Brain E,Cardoso MJ,Chibaudel B,Coleman R,Cufer T,Dallago L,Dalenc F,Deazambuja E,Debled M,Delaloge S,Filleron T,Gligorov J,Gutowski M,Jacot W,Kirkove C,MacGrogan G,Michiels S,Negreiros I,Offersen BV,Penault-Llorca F,Pruneri G,Roche H, Ann Oncol n°10 - pp 1
Guidelines for time-to-event endpoint definitions in Breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
2015 - Gougou-Bourgade S,Cameron D,Poortmans P,Asselain B,Azria D,Cardoso F,AhernRoger R,Judith JB,Jan JB,Herve HB,Etienne EB,Cardoso JM,Chibaudel B,Coleman R,Cufer T,DalLago L,Dalenc F,Penault-Llorca F,Pruneri G,Roche H Ann Oncol n°Feb 27 - pp 1
Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation
2015 - Benusiglio PR,Colas C,Rouleau E,Uhrhammer N,Romero P,Remenieras A,Moretta J,Wang Q,Depauw A,Buecher B,Stoppa-Lyonnet D,Mouret-Fourme E,Nogues C,DiMaria M,Tlemsani C,Warcoin M,Grandjouan S,Malka D,Caron O,Blayau M J Med Genet n°29 - pp 1
Highly efficient radiosensitization of human glioblastoma and lung cancer cells by a G-quadruplex DNA binding compound
2015 - Merle P,Gueugneau M,Teulade-Fichou MP,Muller-Barthelemy M,Amiard S,Chautard E,Guetta C,Dedieu V,Communal Y,Mergny JL,Gallego M,White C,Verrelle P,Tchirkov A Sci Rep n°6 - pp 1
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
2015 - Fkihmhamed I,Privat M,Ponelle F,Penault-Llorca F,Kenani A,Bignon YJ Cell Oncol n°38 - pp 433-42
Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial.
2015 - Talvas J,Garrait G,Goncalves-Mendes N,Rouanet J,Vergnaud-Gauduchon J,Kwiatkowski F,Bachmann P,Bouteloup C,Bienvenu J,Vasson MP Clin Nutr n°34(5) - pp 810-7
Impact Of Her2 Testing Quality Improvement From A Health Economic Perspective
2015 - Tilleul P,Bellocq J,Tehard B,Penault-Llorca F,Salomon A,Antoine E Value Health n°18 - pp 1
Informing the family: Emotions and attitudes of oncogenetic counselees for familial breast/ovarian and/or colon cancer risk.
2015 - Kwiatkowski F, Laquet C,Dessenne P, Bignon YJ Bull Cancer n°27 - pp 1